Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

References for PMC Articles for PubMed (Select 21264206)

1.

The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes.

Stratakis CA, Tichomirowa MA, Boikos S, Azevedo MF, Lodish M, Martari M, Verma S, Daly AF, Raygada M, Keil MF, Papademetriou J, Drori-Herishanu L, Horvath A, Tsang KM, Nesterova M, Franklin S, Vanbellinghen JF, Bours V, Salvatori R, Beckers A.

Clin Genet. 2010 Nov;78(5):457-63. doi: 10.1111/j.1399-0004.2010.01406.x.

2.

Role of the high mobility group A proteins in the regulation of pituitary cell cycle.

Fedele M, Fusco A.

J Mol Endocrinol. 2010 Jun;44(6):309-18. doi: 10.1677/JME-09-0178. Epub 2010 Mar 10. Review.

3.

Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions.

Zhang X, Rice K, Wang Y, Chen W, Zhong Y, Nakayama Y, Zhou Y, Klibanski A.

Endocrinology. 2010 Mar;151(3):939-47. doi: 10.1210/en.2009-0657. Epub 2009 Dec 23.

4.

Genetic factors in the development of pituitary adenomas.

Vandeva S, Tichomirowa MA, Zacharieva S, Daly AF, Beckers A.

Endocr Dev. 2010;17:121-33. doi: 10.1159/000262534. Epub 2009 Nov 24. Review.

PMID:
19955762
5.

The epidemiology and genetics of pituitary adenomas.

Daly AF, Tichomirowa MA, Beckers A.

Best Pract Res Clin Endocrinol Metab. 2009 Oct;23(5):543-54. doi: 10.1016/j.beem.2009.05.008. Review.

PMID:
19945022
6.

Advances in the Diagnosis, Treatment, and Molecular Genetics of Pituitary Adenomas in Childhood.

Keil MF, Stratakis CA.

US Endocrinol. 2009 Feb 1;4(2):81-85. No abstract available.

7.

Influence of growth and transcriptional factors, and signaling molecules on early human pituitary development.

Bazina M, Vukojevic K, Roje D, Saraga-Babic M.

J Mol Histol. 2009 Aug;40(4):277-86. doi: 10.1007/s10735-009-9239-9. Epub 2009 Nov 17.

PMID:
19921443
8.

Acromegaly pathogenesis and treatment.

Melmed S.

J Clin Invest. 2009 Nov;119(11):3189-202. doi: 10.1172/JCI39375. Epub 2009 Nov 2. Review.

9.

Regulation of pituitary function by cytokines.

Haedo MR, Gerez J, Fuertes M, Giacomini D, Páez-Pereda M, Labeur M, Renner U, Stalla GK, Arzt E.

Horm Res. 2009;72(5):266-74. doi: 10.1159/000245928. Epub 2009 Oct 19. Review.

10.

Signalling pathway alterations in pituitary adenomas: involvement of Gsalpha, cAMP and mitogen-activated protein kinases.

Pertuit M, Barlier A, Enjalbert A, Gérard C.

J Neuroendocrinol. 2009 Nov;21(11):869-77. doi: 10.1111/j.1365-2826.2009.01910.x. Epub 2009 Sep 1. Review.

PMID:
19732293
11.

Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).

Fernandez A, Karavitaki N, Wass JA.

Clin Endocrinol (Oxf). 2010 Mar;72(3):377-82. doi: 10.1111/j.1365-2265.2009.03667.x. Epub 2009 Jul 24.

PMID:
19650784
12.

Familial pituitary adenomas.

Tichomirowa MA, Daly AF, Beckers A.

J Intern Med. 2009 Jul;266(1):5-18. doi: 10.1111/j.1365-2796.2009.02109.x. Review.

PMID:
19522822
13.

Genetic, molecular and clinical features of familial isolated pituitary adenomas.

Daly AF, Tichomirowa MA, Beckers A.

Horm Res. 2009 Apr;71 Suppl 2:116-22. doi: 10.1159/000192448. Epub 2009 Apr 29. Review.

PMID:
19407507
14.

Differential gene expression in models of pituitary prolactin-producing tumoral cells.

Giacomini D, Haedo M, Gerez J, Druker J, Páez-Pereda M, Labeur M, Stalla GK, Arzt E.

Horm Res. 2009 Apr;71 Suppl 2:88-94. doi: 10.1159/000192444. Epub 2009 Apr 29. Review.

PMID:
19407504
15.

Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.

Bertherat J, Horvath A, Groussin L, Grabar S, Boikos S, Cazabat L, Libe R, René-Corail F, Stergiopoulos S, Bourdeau I, Bei T, Clauser E, Calender A, Kirschner LS, Bertagna X, Carney JA, Stratakis CA.

J Clin Endocrinol Metab. 2009 Jun;94(6):2085-91. doi: 10.1210/jc.2008-2333. Epub 2009 Mar 17.

16.

Pituitary tumours: all silent on the epigenetics front.

Dudley KJ, Revill K, Clayton RN, Farrell WE.

J Mol Endocrinol. 2009 Jun;42(6):461-8. doi: 10.1677/JME-09-0009. Epub 2009 Feb 10. Review.

17.

Update on the treatment of pituitary adenomas: familial and genetic considerations.

Daly AF, Beckers A.

Acta Clin Belg. 2008 Nov-Dec;63(6):418-24. Review.

PMID:
19170361
18.

Non-functioning pituitary adenomas infrequently harbor G-protein gene mutations.

Ruggeri RM, Santarpia L, Curtò L, Torre ML, Galatioto M, Galatioto S, Trimarchi F, Cannavò S.

J Endocrinol Invest. 2008 Nov;31(11):946-9.

PMID:
19169048
19.

Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states.

Agarwal SK, Mateo CM, Marx SJ.

J Clin Endocrinol Metab. 2009 May;94(5):1826-34. doi: 10.1210/jc.2008-2083. Epub 2009 Jan 13. Erratum in: J Clin Endocrinol Metab. 2009 Jul;94(7):2674.

20.

p21(Cip1) restrains pituitary tumor growth.

Chesnokova V, Zonis S, Kovacs K, Ben-Shlomo A, Wawrowsky K, Bannykh S, Melmed S.

Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17498-503. doi: 10.1073/pnas.0804810105. Epub 2008 Nov 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk